For years, patients with C3G and IC-MPGN had few options to stop the progression toward kidney failure. Now a new class of FDA-approved C3 inhibitors that targets the root of the complement system can ...

For five decades, scientists have known about a notorious cancer-causing enzyme called SRC. But they always assumed it only ...

A topical cream activated the skin's immune defenses and suppressed tumor growth in two preclinical models of cutaneous ...

Significant anterior glenoid bone loss (> 15%) compromises the success of soft-tissue Bankart repair in recurrent shoulder instability. Bone-augmenting procedures—the coracoid based Latarjet ...